KDM1A and Merkel cell skin cancer: By using an in vitro pharmacological screen to detect epigenetic regulators in MCC, a recent study has identified LSD1 as a pivotal enzyme in tumor grown both in vitro and in vivo and, therefore, a potential therapy target [8].